NTV Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.83M | Sell |
14,339
-387
| -3% | -$74.6K | 0.31% | 85 |
|
|
2025
Q4 | $2.71M | Sell |
14,726
-1
| -0% | -$175 | 0.29% | 84 |
|
|
2025
Q3 | $2.26M | Sell |
14,727
-1,088
| -7% | -$165K | 0.25% | 91 |
|
|
2025
Q2 | $2.21M | Sell |
15,815
-600
| -4% | -$84.1K | 0.26% | 84 |
|
|
2025
Q1 | $2.41M | Sell |
16,415
-300
| -2% | -$43.4K | 0.32% | 72 |
|
|
2024
Q4 | $2.19M | Sell |
16,715
-3,330
| -17% | -$466K | 0.29% | 72 |
|
|
2024
Q3 | $3.12M | Buy |
20,045
+2,138
| +12% | +$345K | 0.42% | 62 |
|
|
2024
Q2 | $2.79M | Buy |
17,907
+14,907
| +497% | +$2.24M | 0.4% | 64 |
|
|
2024
Q1 | $407K | Hold |
3,000
| – | – | 0.06% | 184 |
|
|
2023
Q4 | $404K | Hold |
3,000
| – | – | 0.07% | 180 |
|
|
2023
Q3 | $406K | Hold |
3,000
| – | – | 0.07% | 179 |
|
|
2023
Q2 | $429K | Hold |
3,000
| – | – | 0.07% | 173 |
|
|
2023
Q1 | $416K | Hold |
3,000
| – | – | 0.08% | 172 |
|
|
2022
Q4 | $407K | Hold |
3,000
| – | – | 0.08% | 162 |
|
|
2022
Q3 | $329K | Hold |
3,000
| – | – | 0.07% | 173 |
|
|
2022
Q2 | $396K | Hold |
3,000
| – | – | 0.08% | 169 |
|
|
2022
Q1 | $398K | Hold |
3,000
| – | – | 0.07% | 178 |
|
|
2021
Q4 | $350K | Hold |
3,000
| – | – | 0.06% | 195 |
|
|
2021
Q3 | $360K | Hold |
3,000
| – | – | 0.06% | 187 |
|
|
2021
Q2 | $359K | Hold |
3,000
| – | – | 0.06% | 175 |
|
|
2021
Q1 | $298K | Hold |
3,000
| – | – | 0.06% | 186 |
|
|
2020
Q4 | $300K | Hold |
3,000
| – | – | 0.06% | 169 |
|
|
2020
Q3 | $329K | Hold |
3,000
| – | – | 0.08% | 149 |
|
|
2020
Q2 | $317K | Hold |
3,000
| – | – | 0.08% | 148 |
|
|
2020
Q1 | $268K | Hold |
3,000
| – | – | 0.09% | 147 |
|
|
2019
Q4 | $299K | Sell |
3,000
-500
| -14% | -$47.1K | 0.08% | 149 |
|
|
2019
Q3 | $312K | Hold |
3,500
| – | – | 0.09% | 141 |
|
|
2019
Q2 | $289K | Hold |
3,500
| – | – | 0.08% | 149 |
|
|
2019
Q1 | $283K | Sell |
3,500
-250
| -7% | -$19.7K | 0.08% | 147 |
|
|
2018
Q4 | $285K | Hold |
3,750
| – | – | 0.09% | 142 |
|
|
2018
Q3 | $297K | Hold |
3,750
| – | – | 0.08% | 158 |
|
|
2018
Q2 | $263K | Hold |
3,750
| – | – | 0.07% | 158 |
|
|
2018
Q1 | $262K | Sell |
3,750
-250
| -6% | -$17.3K | 0.07% | 162 |
|
|
2017
Q4 | $278K | Sell |
4,000
-500
| -11% | -$33.7K | 0.08% | 157 |
|
|
2017
Q3 | $305K | Buy |
4,500
+500
| +13% | +$31.6K | 0.09% | 153 |
|
|
2017
Q2 | $272K | Hold |
4,000
| – | – | 0.08% | 155 |
|
|
2017
Q1 | $249K | Hold |
4,000
| – | – | 0.08% | 152 |
|
|
2016
Q4 | $218K | Sell |
4,000
-250
| -6% | -$14.2K | 0.08% | 155 |
|
|
2016
Q3 | $279K | Buy |
+4,250
| New | +$278K | 0.1% | 144 |
|
Other funds holding AZN
IA
VCM
VAM
NTV Asset Management's AZN Position: Q1 2026 in Review
NTV Asset Management reduced its AstraZeneca (AZN) stake by 2.6% in Q1 2026, selling an estimated $74.6K and leaving 14,339 shares worth $2.83M. The position accounts for 0.31% of the portfolio, ranked #85.
NTV Asset Management first reported a position in AZN in Q3 2016 and has held it in 39 quarters since. The position peaked at $3.12M in Q3 2024. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- NTV Asset Management held 14,339 shares of AstraZeneca worth $2.83M as of Q1 2026.
- NTV Asset Management sold 387 AstraZeneca shares in Q1 2026, an estimated $74.6K.
- AstraZeneca made up 0.31% of NTV Asset Management's portfolio in Q1 2026, its #85 holding.
- NTV Asset Management first reported a position in AstraZeneca in Q3 2016 and has held it in 39 quarters since.
- NTV Asset Management's AstraZeneca position peaked at $3.12M in Q3 2024.
- 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on NTV Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.